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Abstract Among the long-term complications of Classic
Galactosaemia (Gal) is premature ovarian insufficiency
(POI) in female patients with subtle abnormalities of
reproductive function also reported in male patients. Leptin
is a circulating hormone which reflects body energy stores
and which affects the neuroendocrine reproductive axis and
pubertal development.
We measured serum leptin in 28 children (10 girls, 18
boys; mean age 7.6 years, range 0.5–17.9 years) and in 22
adults (10 females, 12 males; mean age 23.9 years, range
18–37 years) with Gal on a strict galactose-restricted diet in
comparison with control data.
Leptin levels (expressed as SDS for gender and pubertal
stage) were lower in Gal children than controls (mean
leptin-SDS ¼ –0.71 for girls, p < 0.05, –0.97 for boys
compared with SDS ¼ 0 for controls, p < 0.05). In an
age-related analysis, leptin levels did not correlate with
age in children with Gal for both sexes as it did for
matched controls.
As expected, females had higher leptin levels than males
in either group. In adults with Gal, leptin concentrations
were within normal limits for both sexes when adjusted for
gender and BMI. There was a linear relationship between
log-leptin and BMI in children with Gal and in controls.
For Gal women, log-leptin was also associated with BMI.
However, for Gal men, and hence for the entire group of
adult Gal patients, this association between log-leptin and
BMI was not detectable. Our findings suggest that leptin
dysregulation may play a role in fertility issues in
individuals with Gal from an early age.
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Classic Galactosaemia (Gal; OMIM 230400) is an autoso-
mal recessive disorder which is characterised by a defi-
ciency of galactose-1-phosphate uridyltransferase (GALT).
Mutation p.Q188R in the GALT gene is the most common
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mutation in patients with Gal. Despite newborn screening
and early treatment with a strict galactose-restricted diet,
a high percentage of patients experience long-term compli-
cations such as speech deficits, tremor, cognitive and/or
behavioural impairment, and osteopenia in both sexes as
well as primary or premature ovarian insufficiency (POI) in
females (Hughes et al. 2009; Fridovich-Keil et al. 2011).
POI is a spectrum disorder of ovarian insufficiency which
may range from subfertility to primary amenorrhoea or
demonstrate a fluctuating course of ovarian dysfunction.
POI can be detected by measuring follicle-stimulating
hormone (FSH), luteinising hormone (LH), oestradiol and
anti-Mullerian hormone (AMH) in blood of females
with Gal, but given the inactivity of the hypothalamic-
pituitary-ovarian (HPO) axis in childhood, these levels may
be not sensitive enough to identify ovarian dysfunction in a
presymptomatic state.
Although it is well known that females with Gal have a
high risk of hypergonadotropic hypooestrogenic ovarian
dysfunction along with infertility, the underlying mecha-
nisms for POI in galactosaemic patients remain unknown
(Rubio-Gozalbo et al. 2010). They may comprise, for
example, toxic effects of accumulated galactose and its
metabolites, disturbances in glycoprotein and glycolipid
synthesis, altered cell signalling pathways and dysregulated
gene expression (Coman et al. 2010; Coss et al. 2012a).
FSH levels are often found to be elevated in females with
Gal but biologic activity of gonadotropins was described as
essentially normal (Kaufman et al. 1981; Berry 2008).
Along these lines, FSH isoform patterns did not differ
between patients with Gal and postmenopausal controls
(Gubbels et al. 2011a). Data on ovarian histology in
galactosaemic females is scarce, but hypoplastic or streak
gonads with decreased numbers of primordial follicles
along with reduced or absent intermediate and Graafian
follicles were found, similar to other genetic diseases which
directly affect the ovary (Rubio-Gozalbo et al. 2010; Berry
2008). Hormone replacement therapy (HRT) with oestrogen
and progesterone as appropriate along with clinical moni-
toring are reasonable interventions at the current time.
However, spontaneous pregnancies may occur in women
with Gal, and a predicting factor for the possibility to
conceive is spontaneous menarche (Gubbels et al. 2008).
Males with Gal spontaneously reach puberty but onset of
puberty may be delayed (Rubio-Gozalbo et al. 2010).
Recently Gubbels and colleagues have reported a higher-
than-predicted prevalence of cryptorchidism in Gal males
with subtle decreases in testosterone, inhibin B, semen
volume and sperm count which might indicate mild defects
in Sertoli and Leydig cell function (Gubbels et al. 2011b).
Among the endocrine and metabolic key molecules
which directly modulate the HPO axis is leptin. This is a
146 amino acid non-glycosylated protein which is secreted
predominantly by adipocytes but which is also expressed in
other tissues such as stomach, kidney and liver (Meissner
et al. 2005). Leptin is involved in body weight regulation
and provides information on body energy stores (Knerr
et al. 2006). Leptin is involved in regulation of food intake
and energy expenditure at the hypothalamic level as well as
in reproductive maturation and fertility. It is capable of
increasing oestrogen production through the stimulation of
aromatase expression and activity in luteinized granulosa
cells and adipocytes (Catalano et al. 2003). The leptin
receptor is expressed in the brain and several other tissues
such as liver, stomach, kidney and immune cells (Denver
et al. 2011; Xu et al. 2012). Leptin acts on multiple brain
regions including the brain stem, hypothalamus, hippocam-
pus and ventral tegmental area by activating the cytokine
type 1 leptin receptor which is coupled to the JAK2
signalling mechanism (Trinko et al. 2011). As we have
reported dysregulation of multiple central cell signalling
pathways in Gal (Coman et al. 2010), we proposed to study
circulating leptin levels in children and adults with Gal.
Patients and Methods
Patients
Our study was approved by the Ethics Committee of
Children’s University Hospital, Dublin. Informed consent
was obtained prior to enrolment. We recruited 28 children
and 22 adult Irish Gal patients, including 10 pairs of
siblings, who were being treated at the National Centre for
Inherited Metabolic Disorders, Dublin, and the Metabolic
Unit at The Royal Belfast Hospital for Sick Children. Our
paediatric cohort comprised of 10 girls (age 0.6–17.9 years,
mean 7.7 years.) and 18 boys (age 0.5–16.7 years, mean
7.6 years). All children with Gal were diagnosed on
newborn screening (day 5 of life) or selective screening
(day 1) in the case of a positive family history for Gal and
immediately commenced on a lactose-free diet. The adult
study cohort comprised 10 females (age 19–37 years, mean
25.4 years) and 12 males (age 18–28 years, mean 22.4
years). The mean age at diagnosis in our adult patient group
was 12 days (median 7 days, range day 1–day 45 of life).
Mean age at menarche in female adults was 14.1 years.
(range 12–16 years) and 15.3 for adolescent girls (range
13–17 years); only four female patients had had spontane-
ous puberty and menarche. At the age the blood sample was
taken, all women except one and all but one adolescent girl
were on HRT. Adequate intake of calcium and vitamin D
was also recommended along with physical exercise. All
patients were on a strict galactose-restricted diet for life. No
female patient in this study group had given birth and no
male patient had fathered a child at the time of the study.
In the entire Gal cohort, 46 patients (92%) were
homozygous for the GALT mutation p.Q188R; two siblings
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were compound heterozygous for p.Q188R/p.R333W and
p.Q188R/p.K285N, respectively; and two patients were not
genotyped. Clinical data and serum samples were compiled
during routine outpatient visits. Weight and height were
measured, and BMI calculated as body weight (kg) divided
by height (m) squared.
Leptin Assay
Serum leptin was measured using a human leptin immuno-
assay. A microtitre plate-based DELFIA assay was applied,
and antibodies and standards were purchased from R&D
Systems (R&D Systems Europe, Abingdon UK). The intra-
and inter-assay CVs (%) were between 3.9 % and 7.1 %.
The lower limit of detection was 0.1 ng/ml. Samples were
analysed in duplicate.
Control Data
The control data for our paediatric cohort was obtained by
recruiting apparently healthy age- and sex-matched control
children and adolescents (age range 1–17.0 years). The
control data for adults were obtained from 1,670 healthy
young adults under 45 years of age and stratified according
to gender and BMI. We obtained data from 340 men and
558 women with a BMI less than 25 and 456 men and 316
women with a BMI of 25–29.9 kg/m2. These volunteers
have been recruited for ongoing population-based studies in
the UK after gaining ethical approval in 2004. Exclusion
criteria for our control subjects were chronic diseases such
as obesity, diabetes or cancer, and details are published
elsewhere (Kilpel€ainen et al. 2011).
Statistical Analyses
Accounting for the logarithmic distribution of leptin levels,
leptin standard deviation (SDS) according to gender, BMI
and pubertal stage was calculated using a standard equation
based on published normative data (Blum et al. 1997). In
adults, a base-10 logarithm transformation of serum leptin
concentrations was used to ensure normal distribution of
data. Statistical analyses were performed using Prism 5
Software (GraphPad, La Jolla, CA, USA), including
Pearson correlation, linear regression analysis, and Stu-
dent’s t-test. A significance level of p < 0.05 was chosen
for all comparisons.
Results
In our cohort, we found lower leptin levels and leptin-SDS
in children with Gal than in controls (mean leptin-SDS ¼
–0.71 for girls, –0.97 for boys compared with SDS ¼ 0 for
controls, p < 0.05 for each analysis, Figs. 1, 2). In general,
girls had higher leptin levels than boys (4.4  4.1 for Gal
girls vs. 0.9  0.5 for Gal boys, p < 0.01, and 8.1  3.2
for control girls vs. 2.1  1.4 for control boys, p < 0.05,
Fig. 1).
In an age-related analysis, serum leptin levels did not
correlate with age in the entire paediatric Gal group (r ¼
0.0598, n.s.) or for both sexes (r ¼ 0.1326, n.s., for girls
with Gal, r ¼ –0.0877, n.s., for boys with Gal).
In detail, we also found no significant correlation
between leptin and age when data of prepubertal boys with
Gal was tested separately to exclude effects of rising
testosterone levels (r ¼ –0.4690, n.s.). Conversely, leptin
was found positively correlated to age in our paediatric
control group (r ¼ 0.6546, p < 0.01). In detail, leptin
correlated positively with age in our female paediatric
controls (r ¼ 0.8188, p < 0.01). For our male paediatric
controls, we found a correlation between leptin and age
only in the subgroup of prepubertal boys (r ¼ 0.6655, p <
0.05). We found higher leptin levels along with higher BMI
in women compared to girls with Gal (p < 0.001), and





















Fig. 1 Serum leptin levels for children with Gal and age- and gender-



















Fig. 2 Leptin standard deviation scores (SDS) for gender and
pubertal stage are given for children with Gal and age- and gender-
matched controls as mean values  SD
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lower leptin levels despite higher BMI in men compared to
boys with Gal (p < 0.01). Essentially, serum leptin
concentrations were within normal limits for women and
men with Gal when adjusted for gender and BMI (Fig. 3).
As expected, leptin and log-leptin concentrations in male
adults were lower than in female adults in the entire cohort
(p < 0.0001 for Gal patients, p < 0.00001 for control
subjects, for both comparisons) and also in the subgroup of
individuals with normal body weight (BMI 19–24.9 kg/m2,
p < 0.001 for Gal patients and p < 0.00001 for controls,
respectively, Fig. 3).
A linear regression model was then fitted to determine
the relation between log-leptin and BMI for each gender and
cohort. We found a significant linear relationship between
log-leptin and BMI in children with Gal (r2 ¼ 0.9942, p <
0.0001 for girls, r2 ¼ 0.9939, p < 0.0001 for boys and r2 ¼
0.9888, p < 0.0001 for the entire group of children with
Gal) and also for our control subjects (r2 ¼ 0.8791, p <
0.01 for girls, r2 ¼ 0.8287, p < 0.01 for boys, and r2 ¼
0.8681, p < 0.001 for the entire paediatric control group,
Fig. 4a). Among female adults with Gal, BMI was strongly
associated with log-leptin values (r2 ¼ 0.4793, p < 0.05).
This was also found in healthy controls of both sexes (r2 ¼
0.4700, p <0.00001 for females, and r2 ¼ 0.3800, p <
0.00001 for males, Fig. 4b). However, in male adults with
Gal and, therefore, in the entire group of Gal patients, this
association between log-leptin and BMI was no longer
detectable (r2 ¼ 0.1360, p ¼ 0.2382, n.s. and r2 ¼ 0.0070,
p ¼ 0.7104, n.s., respectively, Fig. 4b).



















Fig. 3 Illustrative data set (mean values  SD) for serum leptin




















































Fig. 4 Linear regression analysis between log-leptin concentration and BMI in children (a) and adults (b) with Gal. Linear regression r2 and
p values for control subjects are also given but data is not shown in this diagram
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Discussion
Our data demonstrate that children with Gal had lower
serum leptin levels than controls, expressed as SDS for
gender and pubertal stage. In an age-related analysis, serum
leptin levels did not correlate with age in our paediatric Gal
group as it did in our control group and peak leptin levels
were lower in children with Gal than in controls. As
expected, females had higher leptin levels than males in
either group. Although leptin concentrations were essen-
tially within normal limits for women and men with Gal
when adjusted for gender and BMI, there was a lack of the
physiological association between BMI and log-leptin in
males and, therefore, also in the entire adult Gal cohort. In
females with Gal on HRT, this strong association between
BMI and log-leptin was preserved.
Fertility issues in female patients with Gal are complex
and multifactorial. Possible mechanisms which may under-
lie POI in females with Gal may comprise (1) increased
oocyte loss, e.g. due to direct toxic effects of galactose and
its metabolites or due to hypoglycosylation; (2) altered
dynamics of follicle development, e.g. due to dysregulated
balance of apoptosis and survival pathways in the folliculo-
genesis; (3) perturbated gene expression pattern along with
metabolic dyshomeostasis; and (4) altered follicle matura-
tion due to reduced biopotency of nurturing factors such as
FSH or others (Coman et al. 2010; Rubio-Gozalbo et al.
2010; Fridovich-Keil et al. 2011; Coss et al. 2012a). We
have described earlier that, consistent with the international
experience, 91.2% of females with Gal suffer from hyper-
gonadotropic hypogonadism along with pubertal delay and
fertility issues (Coss et al. 2012b).
Leptin is a key molecule for pubertal development in
many mammalian species. It has been proposed that leptin
may exercise immediate action in the function of the
reproductive glands and leptin receptors have been identi-
fied in ovaries and testes (Goumenou et al. 2003).
Essentially, leptin levels increase in early pubertal stages
but to a higher extent in girls than in boys due to an
increase in testosterone in the latter (Garcia-Mayor et al.
1997). These differences and age-dependence of leptin
concentrations become especially evident after appropriate
logarithmic transformation (Blum et al. 1997). Essentially,
there is a significant correlation of leptin, or log-transformed
values of leptin, and BMI in healthy males and females
of a wide age range (5–77 years) (Isidori et al. 2000;
Gómez et al. 2003; Falorni et al. 1997). Contrary to what is
expected, there was a lack of a correlation between
log-leptin and BMI in adult males with Gal and in our
entire adult Gal cohort. Along these lines, one might
explain the differences between our paediatric and adult
Gal cohort, at least partly, by the chronic nature of this
disorder. Ninety percent of women in our study have been
treated with HRT at the time the sample was taken which
might contribute to subsequent normal leptin levels in these
individuals. Therefore, our findings do not rule out partial
leptin deficiency in galactosaemic women who do not use
HRT, or an individual susceptibility to low leptin levels that
may act as a ‘second hit’. It has been shown, for example,
that leptin serum levels declined in women who underwent
bilateral ovariectomy for benign reasons and that treatment
with oestrogen and progesterone prevented a decrease in
leptin concentrations (Messinis et al. 2000).
The essential role of leptin in fertility is highlighted by
the fact that mice lacking leptin (ob/ob mice) or leptin
receptor (db/db mice) are typically infertile as they fail to
enter puberty (Donato et al. 2011). Leptin deficiency in
mice is associated with impaired folliculogenesis and
increased follicular atresia (Hamm et al. 2004), findings
reminiscent of those seen in ovarian tissues obtained from
females with Gal. Female offspring of pregnant rats placed
on a high galactose diet show altered germ cell migration,
increased rate of follicular atresia, attenuated FSH bioactiv-
ity and a higher galactose-incorporation of serum proteins
compared with control animals (Banerjee et al. 2012).
Among the follicular survival factors are gonadotropins and
integrin (Hussein 2005). Isolated galactose-treated rat
granulosa cells demonstrated increased expression of p53,
a protein which can facilitate apoptosis and cell cycle arrest.
In principle, apoptosis takes place predominantly in oocytes
during foetal life and in granulosa cells of secondary and
antral follicles during adult life, and there are subsequent
mechanisms which eventually lead to apoptosis in these
cells (Hussein 2005). It is unclear at present whether
females with Gal experience disturbed development or a
progressive loss of ovarian tissue or, most likely, both, as
the ovarian tissue in humans is vulnerable throughout life
(Fridovich-Keil et al. 2011).
An association between galactose absorption and leptin
has been demonstrated; leptin inhibits galactose uptake in
the small intestine (Lostao et al. 1998) by acting on the Na
(+)/glucose cotransporter (Barrenetxe et al. 2004). We have
shown that glycoprotein processing defects persist in
treated Gal patients which could potentially affect many
cell signalling mechanisms to include leptin-mediated cell
signalling (Coss et al. 2012a). Essentially, patients with
Gal consume considerable amounts of soy products from
birth onwards. These soy products contain isoflavones
(phytooestrogens) which can function as oestrogen agonists
or selective oestrogen receptor modulators. Infants fed with
soy formula have higher concentrations of phytooestrogens
in plasma and urine than breastfed babies; however, it
cannot be concluded that these soy isoflavones are biologi-
cally active (Vandenplas et al. 2011). Along these lines,
human studies did not detect any clinical significance of the
amounts of nutritional phytooestrogens in infants fed with
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soy formula, but animal studies with phytooestrogens
provide conflicting data, including an association between
the intake of a related compound, coumestrol, and
decreased fertility (Vandenplas et al. 2011). In a group of
40 children with Gal who had decreased body weight and
height, body fat mass (FM) has been shown to be correlated
with soy intake (Panis et al. 2005). In this group of patients,
body composition was abnormal, possibly due to their
metabolic defect, decreased levels of IGF-I and/or soy
nutrition as speculated by the authors (Panis et al. 2005).
However, daily isoflavone intake (up to 130 mg/day) had
essentially no effect on leptin levels in healthy premeno-
pausal and postmenopausal women (Phipps et al. 2001).
Oestrogen increases leptin production, but it has been
demonstrated that even high levels of isoflavone consump-
tion do not alter leptin concentrations in females studied
over 3 months (Phipps et al. 2001).
However, data on galactosaemic individuals are lacking
and difficult to obtain given a long-term ‘lactose-free’ diet
and high soy intake. It thus remains speculative whether a
lower FM and higher intake of phytooestrogens may
ultimately lead to pseudo-normal leptin levels.
The relative increase of leptin with BMI during puberty
is comparable in both sexes but the absolute values at a
given BMI are lower in boys in late puberty (Blum et al.
1997). However, leptin is positively correlated with BMI in
healthy boys (El-Eshmawy et al. 2010). Early puberty
might be a particular vulnerable period in individuals at risk
of decreased reproductive capacity. Along these lines,
reduced leptin levels were found in adolescent boys with
constitutional delay of growth and puberty (El-Eshmawy
et al. 2010). Additionally, decreased leptin and its impact
on the reproductive axis may help to explain delayed
pubertal development in adolescent boys with Gal and
perhaps also cryptorchidism in some cases (Gubbels et al.
2011b).
Recent results from our group, as well as others, have
demonstrated abnormal N-glycan processing and assembly
in individuals with Gal (Coss et al. 2012a; Coman et al.
2010). This might affect G-protein-coupled receptors,
including the insulin-like peptide relaxin receptors LGR7
and LGR8 which have roles in reproductive tissue
remodelling. Hypothalamic KiSS-1 neurons, which express
leptin receptors, execute a prominent role in the neuroen-
docrine and metabolic control of fertility, including regula-
tion of the gonadotropic axis and its full activation at
puberty (Tena-Sempere 2006). We speculate that hypolep-
tinaemia may, therefore, contribute to a delay in pubertal
maturation and dysregulation of reproductive function in
individuals with Gal at a neuroendocrine level from an
early age. In addition to gonadal function loss, e.g. POI in
women with Gal, hypoleptinaemia may be an aggravating
factor in individuals with Gal at risk for reproductive
dysfunction. Moreover, gonadal function loss may further
decrease circulating leptin levels independently from age
and BMI (Benetti-Pinto et al. 2010).
In summary, we present data which suggests that leptin
dysregulation may play a role in delayed pubertal matura-
tion and fertility issues from an early age in Gal patients.
Further studies are now needed, including the application to
animal models, to study the impact of altered leptin levels
in Gal.
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Synopsis
Leptin is an interesting key molecule for reproductive
development and fertility and its dysregulation might play a
role in individuals with Gal.
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